DJIA 17,827.75 0.00 0.00%
NASDAQ 4,787.32 0.00 0.00%
S&P 500 2,072.83 0.00 0.00%
market minute promo

Anika Therapeutics, Inc. (NASDAQ: ANIK)

41.58 0.00 (0.00%)

REAL-TIME: Last trade at

Extended Hours: $41.58 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

ANIK $41.58 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $42.76
Previous Close $41.58
Daily Range $41.14 - $43.04
52-Week Range $28.79 - $52.49
Market Cap $603.1M
P/E Ratio 17.82
Dividend (Yield) $0.00 (0.0%)
Volume 175,789
Average Daily Volume 213,078
Current FY EPS $0.00

Sector

Healthcare

Industry

Drugs

Anika Therapeutics, Inc. (ANIK) Description

The Company develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair. Website: http://www.anikatherapeutics.com/

News & Commentary Rss Feed

Anika Therapeutics, Inc Surges On Approval, but Is It Overpriced Now?

Anika (ANIK) won FDA approval for Monovisc, but sales will have to be strong to justify its recent move higher.

Stocks To Buy In Forbes' Best Small Companies List

Update: Anika Therapeutics Q3 2014 Earnings

Center for Medicare & Medicaid Services Announces That A Unique Reimbursement Code Is Assigned To An

Center for Medicare & Medicaid Services Announces That A Unique Reimbursement Code Is Assigned To Anika's MONOVISC Product

Anika Therapeutics' (ANIK) CEO Charles Sherwood on Q3 2014 Results - Earnings Call Transcript

5 Healthcare Stocks With The Lowest PEG Ratio

Buying Biotech

Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest Operating Margin

Taking Stock Of The New Normal: Mark Landy On New Growth Ideas For Biotech Investors

Small-Cap Stocks With Large Growth Potential

Anika Therapeutics' (ANIK) CEO Charles Sherwood on Q2 2014 Results - Earnings Call Transcript

See More ANIK News...

ANIK's Top Competitors

ANIK $41.58 (0.00%)
Current stock: ANIK
$0.00 (0.00%)
Current stock:
MDT $73.48 (0.00%)
Current stock: MDT
COV $100.54 (0.00%)
Current stock: COV